ACETYLHYDRAZINE HEPATOTOXICITY

被引：33

作者：

BAHRI, AK ^{[1
]}

CHIANG, CS ^{[1
]}

TIMBRELL, JA ^{[1
]}

机构：

[1] ROYAL POSTGRAD MED SCH,DEPT CLIN PHARMACOL,CLIN TOXICOL UNIT,LONDON W12 0HS,ENGLAND

来源：

关键词：

D O I：

10.1016/0041-008X(81)90343-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：561 / 569

页数：9

共 22 条

[1] BACK KC, 1978, AVIAT SPACE ENVIR MD, V49, P591
[2] Balo J, 1979, Adv Cancer Res, V30, P151, DOI 10.1016/S0065-230X(08)60896-9
[3] BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470
[4] TISSUE SULFHYDRYL GROUPS
ELLMAN, GL
[J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) : 70 - 77
[5] CYTOCHROME-P-450 DISTRIBUTION IN RAT-LIVER AND EFFECT OF SODIUM PHENOBARBITONE ADMINISTRATION
GOODING, PE
CHAYEN, J
SAWYER, B
SLATER, TF
[J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1978, 20 (03) : 299 - 310
[6] JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195
[7] INHIBITION OF DIPHENYLHYDANTOIN METABOLISM IN RATS AND IN RAT LIVER MICROSOMES BY ANTITUBERCULAR DRUGS
KUTT, H
VEREBELY, K
MCDOWELL, F
[J]. NEUROLOGY, 1968, 18 (07) : 706 - &
[8] LEES A W, 1971, Tubercle, V52, P182, DOI 10.1016/0041-3879(71)90041-9
[9] RIFAMPIN PLUS ISONIAZID IN INITIAL THERAPY OF PULMONARY TUBERCULOSIS AND RIFAMPIN AND ETHAMBUTOL IN RETREATMENT CASES
LEES, AW
TYRRELL, WF
SMITH, J
ALLAN, GW
FALLON, RJ
[J]. CHEST, 1972, 61 (06) : 579 - &
[10] LOWRY OH, 1951, J BIOL CHEM, V193, P265